Who founded 3T Biosciences?

3T Biosciences was founded by K. Christopher Garcia, Marvin Gee in 2017.

Who are 3T Biosciences's investors?

3T Biosciences's investors include Asset Management Company, CRV (Charles River Ventures), Westlake Village BioPartners, Menlo Ventures, OS Fund, Starlight Ventures.

Where is 3T Biosciences headquartered?

3T Biosciences is headquartered in South San Francisco, US.

3T Biosciences

South San Francisco, US · Founded 2017 · 24 employees on LinkedIn · 6 known investors

Find your way into 3T Biosciences

1,068 people in our graph share verified history with the 3T Biosciences team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Marvin Gee · together at Stanford University (overlapped)

×9knows the team · via Stanford University

×2knows the team · via Caltech

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.

AI & Machine Learning Biotech Healthtech Medical Devices

Founders & leadership

3T Biosciences was founded in 2017 by K. Christopher Garcia and Marvin Gee.

K. Christopher Garcia

Marvin Gee inChief Research Officer, Co-FounderFounder of 3T Biosciences, which develops TCR-based immunotherapies for cancer. Combines experimental and computational approaches in immunology and immuno-oncology.

Investors · 6

Asset Management CompanyMenlo Park · $500K – $2M

CRV (Charles River Ventures)Bay Area · $250K – $5M

Westlake Village BioPartnersLos Angeles · $100K – $5M

Menlo VenturesreportedSan Francisco · $1M – $20M

OS FundreportedPark Ridge · $1M – $2M

Starlight VenturesreportedMiami · $100K – $3M

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AAug 2022
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

Third Arc Bio11 shared keywordsThird Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering. The company is led by a team with a track record of 35+ drug approvals.

3Bar Biologics10 shared keywords

Companies competing with 3T Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

3T Biosciences Raises $40M in Series A Financingfinsmes.com · Aug 2022

Peter Thiel, Sean Parker invest in 3T Bioscieneces to fight cancercnbc.com · Oct 2017

Frequently asked questions

What does 3T Biosciences do?: 3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
Who founded 3T Biosciences?: 3T Biosciences was founded by K. Christopher Garcia, Marvin Gee in 2017.
Who are 3T Biosciences's investors?: 3T Biosciences's investors include Asset Management Company, CRV (Charles River Ventures), Westlake Village BioPartners, Menlo Ventures, OS Fund, Starlight Ventures.
Where is 3T Biosciences headquartered?: 3T Biosciences is headquartered in South San Francisco, US.